Drug repurposing also represents an interesting strategy, since P2X7 antagonists already evaluated in inflammatory diseases such as rheumatoid arthritis could be repositioned for Chagas disease, potentially shortening development timelines and costs [77]. This evidence concerns the gene P2RX7 and Chagas disease.